Lam Research slides as UBS trims target and insider sells

Shares of Lam Research Corporation (NASDAQ: LRCX ) are trading lower Tuesday afternoon as the stock faces a combination of a sell-side price target trim, an insider transaction disclosure and widespread macroeconomic selling pressure across high-multiple tech names.

Lam Research stock is feeling bearish pressure.

What’s behind LRCX decline? UBS Target Trim and Insider Form 4 Disclosure Adding near-term pressure to the stock, UBS lowered its price target on Lam Research to $425 from $435 while maintaining a Buy rating on the shares.

The sell-side adjustment coincided with an SEC Form 4 filing revealing that Chief Legal Officer Ava Harter sold 5,000 shares of common stock at an average price of $302.46 per share on Aug.

31.

The $1.51 million transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted in April 2026.

Yield Surge and Macro Volatility Hit Semiconductor Valuations Broader market headwinds further compounded losses across the semiconductor sector.

Bond markets surged on Tuesday, pushing the 10-year Treasury yield up to 4.8%, its highest level since January 2025, and the 30-year yield to 5.25%.

The rate spike occurred despite the U.S.

Treasury Department’s August move to double its long-dated bond buybacks, as investors continue to digest sticky inflation metrics and an expanding federal deficit, with total U.S. debt exceeding $40 trillion.

Paired with a spike in crude oil prices driven by renewed Middle East geopolitical tensions, escalating discount rates continue to weigh on valuation multiples across capital-intensive growth stocks.

LRCX Shares Drop Tuesday Afternoon Lam Research shares were down 3.95% at $289.57 at the time of publication on Tuesday, according to Pro data.

Read Also: Oil Spikes, Defense Stocks Slide: Markets Brace as US Strikes Iran Again Image: Shutterstock